MENU Quick Go

  • HOME
  • News
  • PharmAbcine Notice
PharmAbcine Notice
Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial at 2017 SNO (Society for NeuroOncology) meeting in San Francisco on November 16-
Date 2017-07-30 Hit 67
Attach Files  
Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial at 2017 SNO (Society for NeuroOncology) meeting in San Francisco on November 16-19th, 2017.
List